Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Fengcai Zhu and Lunbiao Cui.
Fengcai Zhu
Connection Strength
0.840
Lunbiao Cui
  1. Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China. J Infect Dis. 2020 08 04; 222(5):746-754.
    View in: PubMed
    Score: 0.224
  2. A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2). Virology. 2020 10; 549:1-4.
    View in: PubMed
    Score: 0.224
  3. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 2020 08; 285:198005.
    View in: PubMed
    Score: 0.220
  4. An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19. Signal Transduct Target Ther. 2021 04 24; 6(1):165.
    View in: PubMed
    Score: 0.059
  5. HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV. J Virol. 2021 01 28; 95(4).
    View in: PubMed
    Score: 0.058
  6. Association of viral load with serum biomakers among COVID-19 cases. Virology. 2020 07; 546:122-126.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.